NDC 24275-0385-01 - Ammonia N 13
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24275-0385
- Requested NDC
- 24275-0385-01
- Package NDCs from labels
- 24275-0385-1, 24275-0385-01
- Manufacturer
- UCSF Radiopharmaceutical Facility
- Effective date
- 2025-11-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ammonia N 13 - UCSF Radiopharmaceutical Facility | UCSF Radiopharmaceutical Facility | 2025-11-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24275-0385-1 | Ammonia N 13 | 10 mL in 1 VIAL, GLASS | INJECTION | 10 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 24275-0385 | AMMONIA N 13 (NH3N13) INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 11 | Current NDC, Legacy NDC, 1 package rows | 20241013_1f93d72b-6595-4f5f-8ecc-664a612471e5.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMMONIA N-13 | ACTIVE INGREDIENT | 9OQO0E343Z | AMMONIA N 13 (NH3N13) INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 1 | |
| AMMONIA N-13 | ACTIVE MOIETY | 9OQO0E343Z | AMMONIA N 13 (NH3N13) INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ammonia N 13 | AMMONIA N-13 | Biomedical Research Foundation of Northwest Louisiana | a4a2bb1a-1ecc-48e4-a87b-60fc583f61ce | 2026-06-10 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N-13 | Ionetix Corporation | 61e196ba-3812-4ffd-8032-12b215378fef | 2026-04-10 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N-13 | Kreitchman PET Center | 26572b37-0999-4c83-8206-1c088026d407 | 2026-01-27 | Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N-13 | 3D Imaging Drug Design and Development LLC | fce62c22-a1e2-4193-8de5-e1961d9b94a5 | 2026-01-07 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N-13 | Mayo Clinic | af70d0da-1c2d-44e4-b4cd-7cce6636c7b9 | 2025-12-26 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N-13 | PETNET Solutions, Inc. | b1559f8a-1fc8-4a9e-b4f4-5e2efcb1f12c | 2025-12-03 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | NH3N13 | UCSF Radiopharmaceutical Facility | 1f93d72b-6595-4f5f-8ecc-664a612471e5 | 2025-11-14 | Warnings, Adverse reactions | ANDA204496 24275-0385-1 24275-0385 24275038501 4395ab05-b76f-e5ca-e063-6294a90a7f8a 1f93d72b-6595-4f5f-8ecc-664a612471e5 9OQO0E343Z |
| Ammonia N 13 | NH3N13 | University of Alabama at Birmingham | bbc03271-8d23-4e89-aa32-cff581cdc275 | 2025-10-15 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N 13 | University of Wisconsin System | 730595b1-605c-40a2-8f89-2c3eae98f88a | 2025-10-14 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | NH3N13 | The Johns Hopkins University | 80121d8f-fb9d-4122-9e12-33b4ba4f2b9a | 2025-10-14 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N-13 | SOFIE Co. dba SOFIE | 85882893-0661-46c2-a5f2-a73f6ea4fb5a | 2025-04-03 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N 13 | SOFIE Co. dba SOFIE | d24f8595-2231-4f15-ac2b-9148ec453324 | 2025-04-01 | Warnings, Adverse reactions | 9OQO0E343Z |
| AMMONIA N-13 | AMMONIA N-13 | Precision Nuclear LLC | cc430bfd-6940-41ca-bda4-6d29eb4dc1f2 | 2024-12-11 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N-13 | AMMONIA N-13 | The Methodist Hospital Research Institute | c79222b1-7dd8-f1fe-e053-2a95a90a3639 | 2023-12-19 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N-13 | The University of Texas Southwestern Medical Center | e901d193-527d-4e39-8727-c152b56fb9e2 | 2022-11-17 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | AMMONIA N-13 | Massachusetts General Hospital | 57947a8c-939e-4468-805c-2f2001041fe4 | 2021-11-25 | Warnings, Adverse reactions | 9OQO0E343Z |
| AMMONIA N-13 | AMMONIA N-13 | Brigham and Women's Hospital, Inc., The | 3c3c98bd-a052-4564-a15f-37dc6d032707 | 2021-11-03 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | NH3N13 | Washington University School of Medicine | 611f4a03-5b6f-420a-925e-adb905bf7b51 | 2021-10-29 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N 13 | NH3N13 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | c857724f-b172-4844-ad42-6fa4c42b0405 | 2019-10-30 | Warnings, Adverse reactions | 9OQO0E343Z |
| Ammonia N-13 | AMMONIA N-13 | Cardinal Health 414, LLC | 4c563174-c7cd-4224-b865-4da2f39c21c0 | 2018-07-11 | Warnings, Adverse reactions | 9OQO0E343Z |